FPRX
Hudson Bay Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-74,800
| Closed | -$2.82M | – | 1257 |
|
|
2021
Q1 | $2.82M | Sell |
74,800
-375,200
| -83% | -$14.1M | 0.03% | 454 |
|
|
2020
Q4 | $7.66M | Buy |
450,000
+415,000
| +1,186% | +$7.06M | 0.08% | 147 |
|
|
2020
Q3 | $165K | Hold |
35,000
| – | – | ﹤0.01% | 477 |
|
|
2020
Q2 | $213K | Sell |
35,000
-105,000
| -75% | -$639K | ﹤0.01% | 421 |
|
|
2020
Q1 | $318K | Sell |
140,000
-220,000
| -61% | -$500K | 0.01% | 379 |
|
|
2019
Q4 | $1.65M | Sell |
360,000
-75,000
| -17% | -$344K | 0.04% | 281 |
|
|
2019
Q3 | $1.69M | Buy |
435,000
+15,000
| +4% | +$58.1K | 0.05% | 258 |
|
|
2019
Q2 | $2.53M | Buy |
420,000
+65,000
| +18% | +$392K | 0.06% | 221 |
|
|
2019
Q1 | $4.76M | Buy |
355,000
+5,000
| +1% | +$67K | 0.06% | 160 |
|
|
2018
Q4 | $3.26M | Buy |
350,000
+145,000
| +71% | +$1.35M | 0.04% | 218 |
|
|
2018
Q3 | $2.85M | Buy |
205,000
+55,000
| +37% | +$766K | 0.04% | 238 |
|
|
2018
Q2 | $2.37M | Buy |
150,000
+50,000
| +50% | +$791K | 0.03% | 255 |
|
|
2018
Q1 | $1.72M | Buy |
+100,000
| New | +$1.72M | 0.04% | 268 |
|
|
2017
Q3 | – | Sell |
-45,000
| Closed | -$1.36M | – | 456 |
|
|
2017
Q2 | $1.36M | Buy |
+45,000
| New | +$1.36M | 0.03% | 239 |
|